Study dryness patterns in eye graft-vs-host disease
Part of Eyes & vision, Immune system & allergy clinical trials.
This study looks at how common and how severe corneal nerve-related dryness is in people with chronic graft-vs-host disease (GVHD) after a stem cell transplant. It may help doctors understand which eye problems are most typical and how best to recognize them early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had an allogeneic stem cell transplant and have chronic GVHD affecting organs other than the eye
- Your dry-eye symptoms are typical for ocular GVHD, with an OSDI score above 13
- Your cornea staining test is abnormal, with a corneal fluorescein staining (CFS) score of 3 or higher
- You likely have no recent eye procedures or eye/nerve-causing conditions, such as corneal thinning or active corneal infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if gentle electrical stimulation around the eye can help relieve dry eye symptoms caused by chronic graft versus host disease (a complication after a stem cell or bone marrow transplant). It is for people with moderate to severe dry eye who have not had recent eye surgeries or certain other eye problems.
This trial studies special stem cell lenses placed on the eye to treat chronic graft-versus-host disease (cGVHD) that causes dry, irritated eyes. It may help if standard eye treatments haven't worked well.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
This study observes patients who have had a stem cell transplant to understand and monitor chronic graft-versus-host disease affecting the eyes. It aims to learn more about this condition to improve future care.
This trial tests whether injecting stem cells around the eyes can help people with severe dry eye caused by graft-versus-host disease (GVHD) after a stem cell or bone marrow transplant. It aims to reduce eye pain and improve vision when standard treatments haven't worked.
Hear when a new Ocular GVHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.